BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Quatremère G, Guiguet M, Girardi P, Liaud MN, Mey C, Benkhoucha C, Barbier F, Cattaneo G, Simon A, Rojas Castro D. How are women living with HIV in France coping with their perceived side effects of antiretroviral therapy? Results from the EVE study. PLoS One 2017;12:e0173338. [PMID: 28264016 DOI: 10.1371/journal.pone.0173338] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.8] [Reference Citation Analysis]
Number Citing Articles
1 Lamori J, Seignez A, Radoszycki L. Patient Satisfaction with Once-Daily Single-Tablet Darunavir, Cobicistat, Emtricitabine, and Tenofovir Alafenamide (DRV/c/FTC/TAF): A Real-World Study of Patient Self-Reported Outcomes in HIV-1–Diagnosed Adults. PPA 2022;Volume 16:83-94. [DOI: 10.2147/ppa.s332555] [Reference Citation Analysis]
2 Marin RC, Behl T, Negrut N, Bungau S. Management of Antiretroviral Therapy with Boosted Protease Inhibitors-Darunavir/Ritonavir or Darunavir/Cobicistat. Biomedicines 2021;9:313. [PMID: 33803812 DOI: 10.3390/biomedicines9030313] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Fumaz CR, Larrañaga-Eguilegor M, Mayordomo-López S, Gómez-Martínez S, González-García M, Ornellas A, Fuster Ruiz de Apodaca MJ, Remor E, Ballester-Arnal R; Spanish Group for the Quality of Life Improvement in HIV or AIDS. Health-related quality of life of people living with HIV infection in Spain: a gender perspective. AIDS Care 2019;31:1509-17. [PMID: 30917676 DOI: 10.1080/09540121.2019.1597959] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
4 Raho-Moussa M, Guiguet M, Michaud C, Honoré P, Palacios C, Boué F, Azghay M, Kansau I, Chambrin V, Kandel T, Favier M, Miekoutima E, Sayre N, Pignon C, Shoai M, Bouchaud O, Abgrall S. Respective roles of migration and social deprivation for virological non-suppression in HIV-infected adults on antiretroviral therapy in France. PLoS One 2019;14:e0213019. [PMID: 30845270 DOI: 10.1371/journal.pone.0213019] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 0.7] [Reference Citation Analysis]
5 Gelaw YK, Adugna B, Tsegaye AT, Melaku T, Kefale B. Coping Strategies for Adverse Effects of Antiretroviral Therapy among Adult HIV Patients Attending University of Gondar Referral Hospital, Gondar, Northwest Ethiopia: A Cross-Sectional Study. AIDS Res Treat 2018;2018:1879198. [PMID: 30631595 DOI: 10.1155/2018/1879198] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
6 Castro R, De Boni RB, Luz PM, Velasque L, Lopes LV, Medina-Lara A, Cardoso SW, De Oliveira MS, Friedman RK, Grinsztejn B, Veloso VG. Health-related quality of life assessment among people living with HIV in Rio de Janeiro, Brazil: a cross-sectional study. Qual Life Res 2019;28:1035-45. [PMID: 30415417 DOI: 10.1007/s11136-018-2044-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 2.0] [Reference Citation Analysis]